Status:
COMPLETED
Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity
Lead Sponsor:
FMH College of Medicine and Dentistry
Conditions:
Covid19
Eligibility:
All Genders
17-75 years
Brief Summary
The hemostatic abnormalities in COVID-19 are related with disease progression, severity and mortality. The Objective of our study is to evaluate the role of hematological parameters in determination o...
Detailed Description
Objective: COVID-19 virus involves respiratory as well as other body systems including cardiovascular, gastrointestinal, neurological, immunological and hematopoietic system. Patient of covid-19 pneu...
Eligibility Criteria
Inclusion
- diagnosed cases of covid-19 disease
- Both genders
- 17 to 75 year age
Exclusion
- known case of chronic liver disease
- known hematological diseases were excluded
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04670328
Start Date
May 1 2020
End Date
July 31 2020
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FMH college of medicine and dentistry
Lahore, Punjab Province, Pakistan, 54000